RMC 035

Drug Profile

RMC 035

Alternative Names: A1M-001; Alpha-1-microglobulin - A1M Pharma; RMC-035; ROSGard; α1-microglobulin - A1M Pharma

Latest Information Update: 13 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator A1M Pharma AB
  • Class Recombinant proteins; Urologics; Vascular disorder therapies
  • Mechanism of Action Antioxidants; Free radical scavengers; Haemoglobin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Preeclampsia
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Preeclampsia
  • Preclinical Acute kidney injury; Radiation injuries

Most Recent Events

  • 31 Jan 2018 A1M Pharma submits an application to the Swedish Medical Products Agency for a phase I trial in Acute kidney injury (Prevention, In volunteers) in Sweden
  • 05 Jan 2018 A1M Pharma and Antaros Medical initiates enrolment in a clinical program to assess the adverse effects of PRRT radiotherapy in Sweden
  • 14 Nov 2017 A1M completes GLP toxicity studies in Radiation therapies
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top